Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome

9 Feb 2016

Abstract excerpt

Glioblastoma (GBM) is one of the deadliest human cancers. Because of the extremely unfavorable prognosis of GBM, it is important to develop more effective diagnostic and therapeutic strategies based on biologically and clinically relevant subclassification systems. Analyzing a collection of seventeen patient-derived glioblastoma stem-like cells (GSCs) by gene expression profiling, NMR spectroscopy and signal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioinformatics and Genomic Networks
Share to Glioma Diagnosis and Treatment
Share to RNA Research and Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26857460
DOI: 10.1038/srep21557

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical OutcomePMID 26857460Read ↗

Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implicationsSemantic proximity Read ↗

Proteogenomic and metabolomic characterization of human glioblastoma.Semantic proximity Read ↗

Integrative multi-omics Analysis Proposes a Metabolic Classification of Gliomas: Distinct Metabolic States, Immune Infiltration, and PrognosisSemantic proximity Read ↗

Proteomic Profiling of Gliomas Unveils Immune and Metabolism-Driven Subtypes with Implications for Anti-Nucleotide Metabolism TherapySemantic proximity Read ↗

Integrative analysis of metabolism subtypes and identification of prognostic metabolism-related genes for glioblastomaSemantic proximity Read ↗

Single-cell and spatial transcriptomic insights into glioma cellular heterogeneity and metabolic adaptationsSemantic proximity Read ↗

Proteogenomics of glioblastoma associates molecular patterns with survivalSemantic proximity Read ↗

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities.Semantic proximity Read ↗

Glioblastoma Metabolism: Insights and Therapeutic StrategiesSemantic proximity Read ↗

Glioblastoma gene expression based subtypes have defined metabolomic statesSemantic proximity Read ↗

Proteogenomics of glioblastoma associates molecular patterns with survivalSemantic proximity Read ↗

Targeting cancer stem‐like cells in glioblastoma and colorectal cancer through metabolic pathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.